Nucleic Acid Synthesis Inhibitors [Pharmacological Action]
Tree Number(s): D019384
MeSH Unique ID: D019384
- 2,6-diaminopurine (Supplementary Concept)
- sulfoquinovosyl diglyceride (Supplementary Concept)
- 1-(beta-D-arabinofuranosyl)-5-ethyluracil (Supplementary Concept)
- 9-beta-D-arabinofuranosylguanosine 5'-triphosphate (Supplementary Concept)
- 1-beta-arabinofuranosyl-5-ethyluracil 5'-triphosphate (Supplementary Concept)
- 1-beta-arabinofuranosyl-5-propyluracil-5'-triphosphate (Supplementary Concept)
- 1-beta-arabinofuranosyl-5-butyluracil-5'-triphosphate (Supplementary Concept)
- fialuridine (Supplementary Concept)
- 5-(2-bromoethyl)-2'-deoxyuridine (Supplementary Concept)
- 5-(2-chloroethyl)-2'-deoxyuridine (Supplementary Concept)
- 4-n-butylanilino dATP (Supplementary Concept)
- 5-(2-bromovinyl)uridine (Supplementary Concept)
- 2',3'-dideoxyguanosine (Supplementary Concept)
- arabinofuranosyl-E-5-iodovinyluracil (Supplementary Concept)
- 3,4-di-O-galloyl-5-O-digalloylquinic acid (Supplementary Concept)
- carbonyldiphosphonate (Supplementary Concept)
- lobucavir (Supplementary Concept)
- digallic acid (Supplementary Concept)
- ganciclovir triphosphate (Supplementary Concept)
- penciclovir triphosphate (Supplementary Concept)
- 2-hexaprenylhydroquinone (Supplementary Concept)
- 1-O-(6'-sulfo-alpha-D-glucopyranosyl)-2,3-di-O-phytanyl-sn-glycerol (Supplementary Concept)
- N(2)-(4-n-butylphenyl)-2'--deoxyguanosine 5'-imidotriphosphate (Supplementary Concept)
- lucidenic acid O (Supplementary Concept)
- lucidenic lactone (Supplementary Concept)
- polycitone A (Supplementary Concept)
- sculezonone A (Supplementary Concept)
- sculezonone B (Supplementary Concept)
- Sch 725680 (Supplementary Concept)
- 1-deoxyrubralactone (Supplementary Concept)
- islatravir (Supplementary Concept)
- G(8-5m)T (Supplementary Concept)
- 5-((1-(2-bromobenzoyl)-5-chloro-1H-indol-3-yl)methylene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione (Supplementary Concept)
- ITBA-16 (Supplementary Concept)
- DAAP1 (Supplementary Concept)
- Ibezapolstat (Supplementary Concept)
- Amanitins (MeSH Term)
- Anisomycin (MeSH Term)
- Arabinofuranosylcytosine Triphosphate (MeSH Term)
- Chromomycins (MeSH Term)
- Dactinomycin (MeSH Term)
- Dichlororibofuranosylbenzimidazole (MeSH Term)
- Distamycins (MeSH Term)
- Echinomycin (MeSH Term)
- Edeine (MeSH Term)
- Fusaric Acid (MeSH Term)
- Hydroxyphenylazouracil (MeSH Term)
- Hydroxyurea (MeSH Term)
- Idoxuridine (MeSH Term)
- Methotrexate (MeSH Term)
- Methylazoxymethanol Acetate (MeSH Term)
- Plicamycin (MeSH Term)
- Zinostatin (MeSH Term)
- Nitracrine (MeSH Term)
- Nogalamycin (MeSH Term)
- Novobiocin (MeSH Term)
- Phleomycins (MeSH Term)
- Rifampin (MeSH Term)
- Rimantadine (MeSH Term)
- Chromomycin A3 (MeSH Term)
- Mercaptopurine (MeSH Term)
- Cytochalasin D (MeSH Term)
- Mitomycin (MeSH Term)
- Fluoroquinolones (MeSH Term)
- Alpha-Amanitin (MeSH Term)
- Pemetrexed (MeSH Term)
- Famciclovir (MeSH Term)
- Telbivudine (MeSH Term)
- emtricitabine tenofovir alafenamide (Supplementary Concept)
- TSAO-T (Supplementary Concept)
- 2'3'-didehydro-2'3'-dideoxyadenosine (Supplementary Concept)
- L-697661 (Supplementary Concept)
- atevirdine (Supplementary Concept)
- 3'-azido-2',3'-dideoxy-5-iodouridine (Supplementary Concept)
- lamivudine, zidovudine drug combination (Supplementary Concept)
- adefovir (Supplementary Concept)
- 3'-azido-3'-deoxyarabinothymidine (Supplementary Concept)
- oltipraz (Supplementary Concept)
- 6-(1-(2,6-difluorophenyl)ethyl)-2-(dimethylamino)-5-methylpyrimidin-4(3H)-one (Supplementary Concept)
- 3'-deoxycytidine (Supplementary Concept)
- 3'-fluoro-2',3'-dideoxyguanosine (Supplementary Concept)
- 1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine (Supplementary Concept)
- loviride (Supplementary Concept)
- emivirine (Supplementary Concept)
- beta-lapachone (Supplementary Concept)
- efavirenz (Supplementary Concept)
- dexelvucitabine (Supplementary Concept)
- 2-cyclopentylthio-6-(1-(2,6-difluorophenyl)ethyl)-3,4-dihydro-5-methylpyrimidin-4(3H)-one (Supplementary Concept)
- capravirine (Supplementary Concept)
- etravirine (Supplementary Concept)
- ammonium trichloro(dioxoethylene-O,O'-)tellurate (Supplementary Concept)
- 3'-azido-2',3'-dideoxy-5-methylcytidine (Supplementary Concept)
- ulonivirine (Supplementary Concept)
- efavirenz, lamivudine, tenofovir disoproxil fumarate drug combination (Supplementary Concept)
- lamivudine, tenofovir disoproxil fumarate drug combination (Supplementary Concept)
- stavudine, lamivudine, nevirapine drug combination (Supplementary Concept)
- GS-9131 (Supplementary Concept)
- abacavir (Supplementary Concept)
- adefovir dipivoxil (Supplementary Concept)
- R-82913 (Supplementary Concept)
- XZ460 (Supplementary Concept)
- XZ456 (Supplementary Concept)
- XZ462 (Supplementary Concept)
- Zidovudine (MeSH Term)
- Dideoxynucleosides (MeSH Term)
- Zalcitabine (MeSH Term)
- Didanosine (MeSH Term)
- Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (MeSH Term)
- Emtricitabine, Rilpivirine, Tenofovir Drug Combination (MeSH Term)
- Emtricitabine (MeSH Term)
- Rilpivirine (MeSH Term)
- Tenofovir (MeSH Term)
- Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (MeSH Term)
- Foscarnet (MeSH Term)
- Stavudine (MeSH Term)
- Lamivudine (MeSH Term)
- Nevirapine (MeSH Term)
- Delavirdine (MeSH Term)
- Phosphonoacetic Acid (MeSH Term)